Share Name Share Symbol Market Type Share ISIN Share Description
Scientific D. LSE:SDI London Ordinary Share GB00B3FBWW43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 18.00p 17.00p 19.00p 18.00p 18.00p 18.00p 14,252.00 07:54:40
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 8.5 0.5 1.2 15.4 15.99

Scientific Digital Imaging Share Discussion Threads

Showing 626 to 647 of 650 messages
Chat Pages: 26  25  24  23  22  21  20  19  18  17  16  15  Older
DateSubjectAuthorDiscuss
19/1/2017
14:03
RNS - the shareholder list here gets even more ridiculously heavyweight, with Oryx buying almost another 3.9m shares and increasing to 8.35m, or 9.4%: Http://www.investegate.co.uk/scientific-dig-imag/rns/holding-s--in-company/201701191254086355U/
rivaldo
19/1/2017
12:16
Synbiosis news: Http://www.synbiosis.com/produlab-pharma/ "Tuesday 17th January 2017 Produlab Pharma uses ProcScan and SynStats to rapidly generate accurate, traceable data on antibiotic potency Cambridge, UK: Synbiosis, a long-established, expert manufacturer of automated microbiological systems, ispleased to announce its ProcScan inhibition zone measurement system is being used together with its SynStats statistical analysis software at specialist Dutch veterinary pharmaceutical firm, Produlab Pharma to accurately and reproducibly assess the quality of veterinary antibiotics. Microbiologists at Produlab Pharma are using the ProcScan automated system to generate images of inhibition zones around antibiotics on large (240 mm x 240 mm) antibiotic susceptibility testing plates. The images are scanned directly into software, which automatically measures zone sizes and these values are transferred into SynStats statistical software. This rapidly analyses the results to provide standard curve and potency data. Using ProcScan in combination with SynStats is helping microbiologists at Produlab Pharma to precisely assess the efficacy of existing and re-engineered antibiotics to treat diseases such as mastitis in cattle. Dave van Reusel, Microbiologist at Produlab Pharma commented: “We used to measure inhibition zones manually with callipers and then record the results on the computer. It would take us 30 minutes to analyse one plate and after this we had no image of our plates to refer to so there was no proof of our results to look at later.” Dave added: “We chose the ProcScan because it is the only system that can image large antibiotic susceptibility testing plates and measure inhibition zones in a 6 x 6 grid. Before we had the ProcScan, it would require hours to analyse a run of 20-30 assay plates, now it takes a fraction of the time and we can record raw plate images to provide evidence for clients or regulators to assess when they need to.” “Data integrity is currently a hot issue across the pharmaceutical industry,” stated Kate George, Senior Divisional Manager at Synbiosis, “scientists at Produlab Pharma are demonstrating that ProcScan and SynStats is a must have combination for quality assurance laboratories where generating accurate, consistent and more importantly, archived raw and analysed data of any antibiotics’ potency are critical requirements.”
rivaldo
17/1/2017
12:38
News: Http://www.syngene.com/genesys-for-precise-imaging-of-stain-free-protein-gels/ "Thursday 12th January 2017 New GeneSys image capture software now available to download Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to announce its GeneSys software has been upgraded to include an icon of pre-set optimised “stain-free” protein gel imaging conditions. This simple to use software, available to download free of charge to existing users of specified Syngene imaging systems, will save set-up time and ensure accurate stain-free protein gel images every time..... etc"
rivaldo
16/1/2017
09:55
Greyingsurfer, hastings and noble3r are correct - notice that the Fund's shareholding has increased by 1.15m shares, it's simply that the placing has diluted their overall interest. SDI is very volatile and illiquid due to its huge ownership of shares by blue chip institutions, and the MMs adjust the price accordingly. Only £6k has been traded today!
rivaldo
16/1/2017
09:53
The previous dips in July, November and December proved excellent add points
pj 1
16/1/2017
09:48
Looking very weak now ?
basem1
12/1/2017
16:44
Greyingsurfer, number of shares prior to triggering transaction - 7706430, resulting situation after trigger 8860277. This is clearly an increase / purchase of shares but still a tiny dilution after placing.
noble3r
12/1/2017
14:59
OK, makes sense thanks
greyingsurfer
12/1/2017
13:43
Greyingsurfer, I'm pretty sure they picked up more in the placing, but overall holding has been reduced through dilution.Business Growth Fund picked the larger chunks up as did Harwood Capital I believe.
hastings
12/1/2017
12:49
Are you sure? The RNS says they've reduced from over 12 to under 10%
greyingsurfer
12/1/2017
10:03
RNS - Octopus Investments have increased their holding by just over 1.15m shares. They now hold 8.86m shares, or 9.97%: Http://www.investegate.co.uk/scientific-dig-imag--sdi-/rns/holding-s--in-company/201701120935320080U/
rivaldo
11/1/2017
14:31
Oh ok, I could not find it on their web-site or in an RNS but that sounds pretty definitive. Thank you
shanklin
11/1/2017
13:56
I have a visit planned to coincide with the interims for a write up, so unless that date is changed between now and then, it should happen on that Tuesday.Hope that helps.H.
hastings
11/1/2017
13:52
hastings What is the source for 24-Jan please?
shanklin
11/1/2017
12:51
Interims due on 24th.
hastings
11/1/2017
12:23
ding dong!
netcurtains
11/1/2017
11:39
Correct rivaldo, I believe Harwood Capital, Herald and Miton also added in the placing.
hastings
11/1/2017
11:34
Today's RNS is clear that the Business Growth Fund have bought 12% of SDI, or 10.77m shares. The Fund will have picked up almost half of the placing shares as they weren't a major shareholder before. Quite a vote of confidence in this still micro-cap company. And it makes the shareholder list even more blue chip than it already was :o))
rivaldo
11/1/2017
11:32
basem1 - Form not correctly filled out - Suggest you phone
pugugly
11/1/2017
11:32
It's a new holding from the placing.Business Growth Fund from my understanding had been keen to come on board for a while, so I would hope that it will look to add in due course.
hastings
11/1/2017
09:43
18.49 to buy, just done a dummy trade. I'll wait it out, seems like a bit of downward pressure at present.
basem1
11/1/2017
09:33
-7.5%, 19p to buy no excuses now!
pj 1
Chat Pages: 26  25  24  23  22  21  20  19  18  17  16  15  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170123 22:53:34